International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 13135 - 13148
Published: Dec. 1, 2024
Skin
radiation
damage
is
a
prevalent
form
of
tissue
injury
encountered
during
radiotherapy,
accidents,
and
occupational
exposure.
The
only
clinically
approved
radioprotective
agent,
amifostine,
associated
with
numerous
side
effects,
underscoring
the
urgent
need
for
development
safe
effective
agents.
Natural
products
reductive
properties
possess
high
antioxidant
activity
biocompatibility,
but
their
low
bioavailability
limits
efficacy
clinical
application.
To
address
this,
we
utilized
epigallocatechin
gallate
(EGCG)
as
model
compound
employed
nanotechnology
to
enhance
cellular
uptake
natural
compounds,
thereby
improving
free
radical
scavenging
capabilities.
Discover Sustainability,
Journal Year:
2024,
Volume and Issue:
5(1)
Published: Nov. 26, 2024
Contrary
to
the
conventional
wisdom
and
practices
moderate
non-burning
ultraviolet
(UV)
radiation
may
be
beneficial
our
existence,
but
ecosystems
human
health
are
seriously
threatened
by
rise
in
UV
from
ozone
layer
loss
climate
change.
Nevertheless,
there
is
less
current
information
on
environmental
effects
of
elevated
stress.
This
review
looks
at
patterns
levels
today
emphasizes
causes,
which
include
anthropogenic
activities
ozone.
With
a
focus
physiological,
cellular,
ecological
mechanisms,
environment,
wildlife,
aquatic
terrestrial
ecosystems,
thoroughly
discussed.
Various
mitigation
tactics,
such
as
technological
ones
like
UV-protective
materials,
biological
breeding
UV-resistant
species,
policy
public
education
international
agreements,
discussed
here.
provides
thorough
understanding
potential
techniques
combining
these
various
strategies.
study
crucial
that
will
help
protect
against
harmful
environment
health.
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 13135 - 13148
Published: Dec. 1, 2024
Skin
radiation
damage
is
a
prevalent
form
of
tissue
injury
encountered
during
radiotherapy,
accidents,
and
occupational
exposure.
The
only
clinically
approved
radioprotective
agent,
amifostine,
associated
with
numerous
side
effects,
underscoring
the
urgent
need
for
development
safe
effective
agents.
Natural
products
reductive
properties
possess
high
antioxidant
activity
biocompatibility,
but
their
low
bioavailability
limits
efficacy
clinical
application.
To
address
this,
we
utilized
epigallocatechin
gallate
(EGCG)
as
model
compound
employed
nanotechnology
to
enhance
cellular
uptake
natural
compounds,
thereby
improving
free
radical
scavenging
capabilities.
